Cargando…
COVID-19-Associated Rhino-orbital mucormycosis: Presentation and outcome
We are reporting four accounts of rhino-orbital mucormycosis in patients during and after recovery from SARS-CoV-2 infection. The patients were diagnosed and treated for COVID-19 according to the current treatment protocols, following which they presented with sudden proptosis, ophthalmoplegia, and...
Autores principales: | Saini, Sanchita, Singh, Satya P., Singh, Vinod K., Kumar, Santosh, Singh, Sanskriti, Rajak, Shiv D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032291/ https://www.ncbi.nlm.nih.gov/pubmed/36968777 http://dx.doi.org/10.4103/sjopt.sjopt_154_21 |
Ejemplares similares
-
Rhino-orbital Mucormycosis
por: Bakshi, Satvinder Singh
Publicado: (2019) -
Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center
por: Singh, Satya Prakash, et al.
Publicado: (2021) -
Rhino-orbital mucormycosis in COVID-19 patients—a new threat?
por: Awal, Sandeep Singh, et al.
Publicado: (2021) -
Rhino-orbital mucormycosis in a COVID-19 patient
por: Baskar, Harithraa Cheniappangoundar, et al.
Publicado: (2021) -
COVID-19 associated rhino–orbital–cerebral mucormycosis—an institutional series
por: Naurka, Suresh, et al.
Publicado: (2022)